{"id":872994,"date":"2025-08-07T19:24:58","date_gmt":"2025-08-07T23:24:58","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/amn-healthcare-announces-second-quarter-2025-results\/"},"modified":"2025-08-07T19:24:58","modified_gmt":"2025-08-07T23:24:58","slug":"amn-healthcare-announces-second-quarter-2025-results","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/amn-healthcare-announces-second-quarter-2025-results\/","title":{"rendered":"AMN Healthcare Announces Second Quarter 2025 Results"},"content":{"rendered":"
\n

\n
\n Quarterly revenue of <\/em>
\n <\/strong>
\n
\n $658 million<\/em>
\n <\/strong>
\n
\n and Adjusted EBITDA of $58.3 million; <\/em>
\n <\/strong>
\n
\n
\n GAAP loss of <\/em>
\n <\/strong>
\n
\n ($3.02)<\/em>
\n <\/strong>
\n
\n \/share and adjusted EPS of <\/em>
\n <\/strong>
\n
\n $0.30<\/em>
\n <\/strong>\n <\/p>\n

DALLAS, Aug. 07, 2025 (GLOBE NEWSWIRE) — \u00a0AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its second quarter 2025 financial results. Financial highlights are as follows:<\/p>\n

Dollars in millions, except per share amounts.<\/p>\n\n\n\n\n\n\n\n\n
\u00a0<\/td>\n\n Q2 2025<\/strong>\n <\/td>\n\n % Change Q2
2024<\/strong>\n <\/td>\n		\n YTD June 30,
2025<\/strong>\n <\/td>\n		\n % Change YTD
June 30, 2024<\/strong>\n <\/td>\n<\/tr>\n
Revenue<\/td>\n$658.2<\/td>\n\u00a0<\/td>\n(11<\/td>\n%)<\/td>\n$1,347.7<\/td>\n\u00a0<\/td>\n(14<\/td>\n%)<\/td>\n<\/tr>\n
Gross profit<\/td>\n$196.4<\/td>\n\u00a0<\/td>\n(15<\/td>\n%)<\/td>\n$394.5<\/td>\n\u00a0<\/td>\n(19<\/td>\n%)<\/td>\n<\/tr>\n
Net loss<\/td>\n($116.2<\/td>\n)<\/td>\nnm<\/td>\n($117.3<\/td>\n)<\/td>\nnm<\/td>\n<\/tr>\n
Diluted loss per share<\/td>\n($3.02<\/td>\n)<\/td>\nnm<\/td>\n($3.06<\/td>\n)<\/td>\nnm<\/td>\n<\/tr>\n
Adjusted diluted EPS*<\/td>\n$0.30<\/td>\n\u00a0<\/td>\n(69<\/td>\n%)<\/td>\n$0.75<\/td>\n\u00a0<\/td>\n(62<\/td>\n%)<\/td>\n<\/tr>\n
Adjusted EBITDA*<\/td>\n$58.3<\/td>\n\u00a0<\/td>\n(38<\/td>\n%)<\/td>\n$122.5<\/td>\n\u00a0<\/td>\n(36<\/td>\n%)<\/td>\n<\/tr>\n<\/table>\n

* See \u201cNon-GAAP Measures\u201d below for a discussion of our use of non-GAAP items and the table entitled \u201cNon-GAAP Reconciliation Tables\u201d for a reconciliation of non-GAAP items.<\/p>\n

\n
\n Business Highlights<\/u>
\n <\/strong>\n <\/p>\n